Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹625.24 Cr |
| Fresh Issue | ₹60.00 Cr |
| Offer for Sale | ₹565.24 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹626.00-627.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 543266 |
| NSE Code | HERANBA |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Batlivala & Karani Securities... |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 23 shares and in multiples thereof
Incorporated in 1992, Heranba Industries Limited is a Gujarat-based crop protection chemical manufacturer. It is one of the leading domestic producers of synthetic pyrethroids like cypermethrin, deltamethrin, lambda-cyhalothrin, etc. The company manufactures different types of pesticides including insecticides, fungicides, herbicides, and other pest control products.
Heranba Industries operates in different verticals including 1. Domestic sales of Technicals to companies 2. Technicals exports, 3. Domestic sales of Branded formulations under its own brand name, 4. Formulations export, and 5. Manufacturing and selling of insect control chemicals. It has a strong network in the domestic as well as the overseas market. In India, it has 8600 dealers across 16 states and 1 union territory whereas, in the overseas market, it exports its products to more than 60 countries through international distribution partners.
The company has 3 well-equipped manufacturing units in Vapi, Gujarat with an aggregate manufacturing capacity of 14,024 MTPA. It further has an in-house R&D team at Unit I and II that are recognized by the Department of Scientific and Industrial Research (DSIR) and its new R&D facility at Unit III, Sarigam will become operational from December 2020.
Competitive strengths
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To fund working capital requirements | 50.00 |
| 2 | General corporate purposes | 7.48 |
| Period Ended | 30 Sep 2020 | 31 Mar 2020 | 31 Mar 2019 | 31 Mar 2018 |
|---|---|---|---|---|
| Assets | 788.12 | 624.76 | 560.44 | 450.47 |
| Total Income | 619.21 | 967.91 | 1,011.84 | 750.41 |
| Profit After Tax | 66.31 | 97.75 | 75.40 | 46.88 |
| EBITDA | 100.14 | 145.88 | 138.81 | 93.13 |
| NET Worth | 381.26 | 320.85 | 228.18 | 157.32 |
| Reserves and Surplus | 342.20 | 281.79 | 189.12 | 149.51 |
| Total Borrowing | 38.02 | 43.08 | 49.87 | 75.99 |
| Amount in ₹ Crore | ||||
